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Abstract
Ophiocoma erinaceus Muller &Troschel (Ophiocomidae) is part of the extensive group 
of echinoderm that contains bioactive metabolites. As  the anti cancer potential of brittle star 
saponin has not been reported against cervical cancer, the present study was conducted to 
evaluate the anticancer effect of extracted crude saponin. Saponin extraction was conducted 
using conventional method such as froth test, TLC, FTIR and erythrolysis assay. The Hela-S3 
cervical carcinoma and HNCF-PI52 normal cells were treated with different concentrations 
of saponin fraction for 24 and 48 h. The cytotoxicity was examined by MTT, DAPI, AO/PI, 
Annexin V-FITC and flow cytometry. In addition, the apoptotic induced pathway was studied 
using caspase assay, evaluation of ROS generation and Bcl-2 mRNA level. Crude saponin 
showed cytotoxic properties in Hela-S3 cells (IC50of 23.4 µg/mL) without significant impact 
against normal cells. In addition, the crude saponin increased sub-G1 peak in flow cytometry 
histogram of treated cells, ROS generation and caspase-3 and -9 activity (IC50 of 11.10, 11.27 
µg/mL). The dose dependent down regulation of Bcl-2 in treated cells demonstrated that 
saponin fraction can trigger intrinsic apoptotic pathway in cancer cells. This study provides 
valuable information about the apoptotic inducing effect of saponin fraction, which can offer 
new insights into the anticancer potential of saponin as a promising candidate against human 
cervical carcinoma.
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Introduction
Ophiuroids have received less attention 
in biomedicine due to insufficient knowledge 
concerning how to deal with the presence of 
therapeutic metabolites (1). The existence 
of bioactive substances, such as steroids, 
naphtaquinone, terpens, phenylpropanoid and 
cerebrosides, have been demonstrated in these 
marine invertebrates (2). 
Saponins are steroidal terpenoids or 
sometimes alkaloid glycosides with several 
health benefits and a wide spectrum of 
pharmacological properties (3). The traditional 
application of saponins involves their usage 
as fish poison, detergents, food additives, 
surfactants for increment generation in milk 
and wool in ruminant production (4). The 
anticancer effect of saponins has been improved 
their pharmacological application in therapeutic 
fields(5).
Cervical cancer is one of the most prevalent 
cancers affecting women with a high rate of 
mortality (6). In spite of the great advances in 
cancer therapeutic methods, cervical cancer still 
represents a life threatening disorder for women 
with the crucial challenge being poor prognosis 
and lack of efficient standard chemotherapy 
approaches (7). The main therapeutic modalities 
for cervical cancer are surgery, radiation therapy 
and chemotherapy (8). 
However, apoptotic resistance is regarded 
as a major problem in response to conventional 
therapeutic methods and a substantial culprit 
for anticancer therapy failure (9). Trigger of 
apoptosis or the suppression of cancer cell 
growth is attributed to a prominent underlying 
mechanism of the anticancer potential of natural 
products (10). High specificity against cervical 
cancer cells along with minimizing the side 
effects on normal cells are considered as the 
main purpose of drug development strategies for 
treatment of cervical cancer (8). 
It has been demonstrated that oxidative 
stress is a prerequisite for promoting HPV-
initiated cervical carcinogenesis and the 
potential cancer chemopreventive activities of 
natural antioxidants such as curcumin, ferulic 
acid, epigallocatechin-3-gallate (EGCG) and 
resveratrol can be promising toward cervical 
carcinoma treatment. Therefore, many 
oncological researchers are concentrating on 
novel therapeutic strategies based on natural 
products that counteract with oxidative stress. 
Previous studies have indicated that saponin 
metabolites show antioxidant efficacy that can 
be consider promising in reducing the danger of 
human cancers (11).
However, evidence-based researches showed 
saponin compounds derived from terrestrial 
sources possess anti cancer efficacy (12), which 
have been documented against cervical cancer. 
Thus, finding bioactive saponins from marine 
sources that selectively suppress cervical cancer 
proliferation without injury to normal tissue 
and prevent uncontrolled cancer cell division 
is critical for cervical cancer therapeutic 
approaches.
Recently we extracted and characterized the 
saponin fraction from the Persian Gulf brittle 
star Ophiocoma erinaceus Muller & Troschel 
(Ophiocomidae) with conventional extraction 
techniques (13).
 In his study, we explored the cytotoxicity 
of saponin fraction extracted from O. erinaceus 
in Hela-S3 cervical cancer and HNCF-PI52 
cervical normal cell lines. In addition, the 
main focus of this study was the assessment of 
apoptosis inducing effect of brittle star saponin 
fraction against cervical cancer cells. 
Experimental
Chemicals
Hela-S3 (cervical cancer cells) and HNCF-
PI52 (normal cervical cells) were purchased 
from NCBI (National Cell Bank of Iran). DMEM 
Medium, FBS (Fetal Bovine Serum), trypsin-
EDTA and antibiotic (Penicillin-streptomycin) 
were obtained from Gibco (USA). Specimens 
of the brittle star (O. erinaceus) were obtained 
from the rocky intertidal flats of the Persian 
Gulf. Methanol and ethanol were purchased 
from Merck (Germany). MTT (3-[4, 5- dimethyl 
thiazol-2-yl]-2,5-diphenyl tetrazolium bromide) 
and DAPI was prepared from AppliChem (USA). 
PI (propodium iodide) and acridine orange were 
obtained from Sigma (USA). Caspase-3 and 
caspase-9 colorimetric assay kits were purchased 
from Abcam (England). 
Extraction and identification of crude saponin 
from brittle star
Saponin fraction was extracted from the brittle 
star, O. erinaceus from the rocky intertidal flats 
of the Persian Gulf, the separation procedure 
was exerted on the basis of (14). Extraction 
method was performed using methanol, 
dichloromethane and n-butanol, sequentially. 
Isolation was performed using diaion HP-20, 
washed with dionized water, eluted with 80% 
and 100% ethanol. Subsequently, the 80% 
ethanol fraction was determined as saponin 
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fraction and confirmation of saponin extraction 
was performed using TLC (Thin Layer 
Chromatography), erythrocyte lysis and FTIR 
(Fourier Transform Infrared spectroscopy) 
which was reported in our previous study (13).
Cell Culture and cytotoxicity
The Hela-S3 and HNCF-PI52 cells, were 
grown in DMEM medium containing 10% FBS 
supplemented with 1% antibiotic at 37 °C in a 
humidified, 5% CO2 incubator. The cells were 
maintained sub-confluent and all experiments 
were repeated at least three times. The inhibitory 
effects of brittle star saponin fraction on the 
growth of Hela-S3 cancer cells and HNCF-
PI52 normal cell proliferation were measured 
by MTT assay. Briefly, the cells were cultivated 
at a concentration of 104 cells/well in 96-well 
plates, overnight. Then the cells incubated 
with appropriate concentrations of brittle star 
saponin fraction (0, 1.5, 3.1, 6.25, 12.5, 25, 50, 
100 µg/mL). The MTT assay was exerted 24 h 
and 48 h after treatment; the growth inhibitory 
effect of saponin fraction was determined 
by the addition of 10 µL MTT solution and 
dissolving formazan crystals with 80 µL DMSO, 
and, eventually, measurement of the optical 
absorbance of the dissolved formazan at 570 nm 
by spectrophotometer (Epoch, USA).
DAPI staining
In this assay, Hela-S3 cells were seeded on a 
coverslip in six well plates and then incubated 
with the different concentrations of brittle star 
saponin fraction for 24 h. Subsequently, the cells 
were fixed with methanol for 5 min at room 
temperature, rewashed and stained with 10 µg/
mL DAPI at 37 °C for 15 min in the dark. Finally, 
morphological changes were observed under 
fluorescence microscope (Olympus, Japan).
Apoptosis detection by Acridine Orange/
Propodium Iodide (AO/PI)
The cervical cancer cells (2 × 104 cells/well) 
treated with a defined concentration of saponin 
fraction for 24 h were harvested and stained with 
10 µL of a dye mixture comprising 100 µg/mL 
Acridine Orange (AO) and Propodium Iodide 
(PI). The cells were then mounted on coverslips 
and visualized under a fluorescence microscope 
for the morphological changes.
Apoptosis analysis with Annexin V-FITC and 
propodium iodide method
For evaluation of apoptosis induced by 
brittle star saponin fraction, the appearance 
of phosphatidylserine on the outer leaflet of 
membrane was evaluated. AnnexinV/propodium 
iodide staining was used with the Apoptosis 
Detection Kit (Abcam, UK) according to the 
manufacture instructions. Briefly, 24 h after 
treatment, Hela-S3 cells were trypsinized and 
resuspended in 500 µL of 1X binding buffer. 
Thereafter, 5 µL of Annexin-V-FITC and 5 µL 
of propodium iodide were added and incubated 
at room temperature for 5 min in the dark. In 
the next step, the samples were analyzed using 
FACSCalibur (Becton Dickinson, USA) flow 
cytometry.
Flow cytometry analysis 
The cultivated Hela-S3 cells were exposed 
with a medium containing certain concentrations 
of brittle star saponin fraction. Then the cells were 
washed twice and resuspended in propodium 
iodide solution containing 0.1% sodium citrate 
plus 0.1% Triton X100 and incubated at 37 °C for 
30 min, and then placed at 4 °C for 10 min and 
the fluorescence of stained cells was evaluated 
using a FACScan laser flow cytometer, and the 
population of cells was calculated using the 
WINMDI software.
Colorimetric Caspase assay
This assay was exerted using a colorimetric 
caspase-3 and -9 assay kit with quantification of 
caspase enzymatic activity according to cleavage 
of p-nitroaniline (pNA) from the labeled 
substrate DEVD-pNA and p-nitroanilide (pNA) 
from the labeled substrate LEHD-p-NA by 
active enzyme, respectively. Briefly, 4 × 106 cells 
were exposed with appropriate concentrations of 
brittle star saponin fraction for 24 h. Then, the 
treated cells were trypsinized and lysed with 300 
µL of chilled Cell Lysis Buffer, and centrifuged 
at 4°C to obtain supernatant cytosolic extract 
rich from protein content. Then, cell lysate were 
examined for measurement of caspase-3 and 
caspase-9 activities after the addition of 5 µL of 
2X reaction buffer (containing dithioreitol) and 
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5 µL of the conjugated substrate and incubation 
at 37 °C for 2 h. Eventually, absorbance was read 
at 405 nm (Epoch, USA).
Measurement of ROS generation
Reactive oxygen species (ROS) production 
was determined by fluorescence microscopy and 
FACS using the method described previously 
with some modification. Briefly, after treatment, 
cells were incubated with (5μM2′-7′-dichloro-
fluorescin diacetate) for 10 min. Cells were 
rinsed with PBS and then the intensity of 
DCFDA fluorescence determining the amount 
of intracellular ROS was analyzed using a flow 
cytometer with an excitation wavelength of 
480 nm and an emission wavelength of 530 nm 
and evaluated under fluorescence microscope; 
photographs were taken.
RNA extraction and RT-PCR analysis of Bcl-
2
In order to evaluate the effect of extracted 
saponin on Bcl-2 mRNA levels, 2×106 Hela-S3 
cells () were treated with different inhibitory 
concentrations of saponin. Then the total cellular 
RNA was isolated using the High Pure RNA 
Isolation kit (Roche, Germany). Total RNA 
(2 µg) was reverse-transcribed to cDNA using 
random hexamer, or oligodT, and RT premix; 
and then amplified using RT-PCR Premix (Pars 
Tous, Iran). First, the produced cDNA (2 µL) 
was added to 10 µL Taq premix, 2 µL forward 
primer, 2µL reverse primer and distilled water 
(Pars Tous, Iran). RT-PCR was performed 1 
cycle reverse transcription at 95 °C/4 min and 35 
cycles as denaturation at 94 °C for 30 s, annealing 
at 59 °C for 30 s, extension at 72 °C for 30 s and 
1 cycles 5 min at 72 °C. The primers were: B2M 
Forward 5ꞌ TGGTGCTTGGCTCACTGACC 3ꞌꞌ 
, Reverse 5ꞌꞌ TATGTTCGGCTTCCCATTCT 3ꞌꞌ 
was  used  as  the  housekeeping  gene. Forward 
5ꞌꞌ CATGTGTGTGGAGAGCGTCAAC 3ꞌ and 
Reverse 5ꞌ CAGATAGGCACCCAGGGTGAT 
3ꞌ for Bcl-2. The PCR products were 
electrophoresed on a 2% agarose gel and 
recorded using UV TEC gel documentation 
system (Cambridge, UK).
Statistical analysis
The results are presented as the mean ± SEM 
and experiments were carried out in triplicate. 
The difference between means was analyzed by 
one-way ANOVA followed by the Tukey test and 
Prism5. The level of p ≤ 0.05 was considered 
significant.
Results and Discussion
In cancerous phenotype evasion of apoptosis 
and increment resistance to apoptosis results 
from up-regulation of anti-apoptotic members 
of Bcl-2 family (15). A variety of extracellular 
and intracellular stimuli can modulate 
mitochondrial mediated cell suicide including 
diverse physicochemical factors, anticancer 
compounds and free radical producing elements. 
Therefore, trying to find bioactive agents that 
elicit apoptosis (programmed cell death) is one 
purpose of cancer therapeutic modalities (16).
In respect of saponins, the high toxicity of 
compounds attributed to the low usefulness of 
compounds as a chemotherapeutic cytotoxic 
agents is one of the major drawbacks in drug 
discovery (17). Therefore, the identification of 
natural saponin with moderate toxicity on tumor 
cell lines may be useful in anticancer therapy (18). 
The permeabilzing properties of saponins have 
been proposed to be a prerequisite mechanism for 
the improvement drug delivery to enhance their 
cytotoxicity in addition to improved endocytosis 
(19). The reduction of metastasis, evocation 
of cell cycle arrest, inhibition of angiogenesis, 
prevention of drug efflux and elicit apoptosis are 
the most common causes of saponin application 
as an antitumor agent (20). 
Although several investigations were 
conducted indicated that the anticancer effect of 
steroidal and terpenoid saponin(21), however, 
there is no documented literature referring to 
the anticancer potential of saponin fraction from 
Persian Gulf brittle star.
To determine the optimal concentrations of 
brittle star saponin fraction, the Hela-S3 cancer 
and HNCF-PI52 normal cells were treated with 
increasing concentrations (0, 3.1, 6.25, 12.5, 
25, 50, 100 µg/mL) for 24 h and 48 h. Then the 
growth inhibitory effect was measured by MTT 
assay. As shown in Figure 1. the proliferation of 
Hela-S3 cancer cells was significantly inhibited 
in a dose dependent manner and the percentage 
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of inhibition rate was 48.3%, 66.4% by 25 and 
50 µg/mL after 24 h treatment (p ≤ 0.001) and 
47.2%, 56.5% by 12.5 and 25 µg/mL after 48 
h treatment(p ≤ 0.001), respectively. However, 
the HNCF-PI52 cells were less sensitive against 
exposure to brittle star saponin fraction, which 
indicated that treatment with brittle star saponin 
fraction administrated low toxicity against 
normal cells without a significant cytotoxic 
effect. The IC50 values of saponin fraction for 
Hela-S3 cells were considered approximately 
23.4 µg/mL, which exhibited an inhibitory effect 
on cancer cells.
The results of DAPI staining exhibited 
chromatin fragmentation under treatment with 
definite concentrations of brittle star saponin 
fraction as one of characteristic of apoptosis 
cell death. In addition, AO/PI staining, through 
which the intact cells can be recognized by the 
green color; apoptotic cells are distinguished by 
the bright green or orange color; and necrotic 
cells by the red color. AO/PI staining revealed 
that exposure of Hela-S3 cancer cells to various 
concentrations of saponin induced apoptosis 
in IC50 value and necrosis cell death in the 




Figure 1: The anti proliferative effect of O. erinaceus saponin fraction on Hela-S3 cervical 
cancer cells (A) and HNCF-PI52 normal fibroblast cells (B) after 24,48 h incubation period. As 
indicated, saponin fraction inhibited cervical cell proliferation dose dependently, p value of 









































































Figure 1. The anti proliferative effect of O. erinaceus saponin fraction on Hela-S3 cervical cancer cells (A) and HNCF-PI52 normal 
fibroblast cells (B) after 24,48 h incubation period. As indicated, saponin fraction inhibited cervical cell proliferation dose dependently, 
p value of *P<0.05, **P<0.01 and ***P<0.00, while did not inhibit normal cell proliferation, significantly.
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fraction; thus indicating apoptosis involvement 
in the cytotoxic effect of brittle star saponin on 
Hela-S3 cancer cells (Figure 2).
To verify the morphological changes under 
the treatment of Hela-S3 cancer cells with IC50 
concentration of saponin fraction Annexin 
V-FITC/PI staining was performed. Flow 
cytometry diagrams (Figure 3A) determined 
the alive, early apoptotic, late apoptotic and 
necrotic cell death rate and demonstrated that 
with increasing concentration of saponin, 
the percentage of Annexin positive cells was 
enhanced remarkably. Hence, the percentage 
of apoptotic cells was gradually promoted from 
2.4  % in the control group to 66.7 and 92.6% 
in the treated groups, which is indicative of the 
pro-apoptotic effect of the treatment with brittle 
star saponin fraction on Hela-S3 cervical tumor 
cells. 
The apoptosis inducing effect of saponin 
 
Figure 2: A) Fluorescence profiles of apoptosis induction by brittle star saponin fraction on 
cervical cancer cells using DAPI staining. (a-d) untreated cancer cells, treatment with 12.5, 25, 
50 µg/ml brittle star saponin, respectively ×400. B) Fluorescence micrographs of brittle star 
saponin fraction on Hela-S3 cancer cells with AO/PI staining.(a-d) untreated cancer cells, 
treatment with 12.5, 25, 50 µg/ml brittle star saponin fraction. Magnification= ×200 
Figure 2. A) Fluorescence profiles of apoptosis induction by brittle star saponin fraction on cervical cancer cells using DAPI staining. 
(a-d) untreated cancer cells, treatment with 12.5, 25, 50 µg/ml brittle star saponin, respectively ×400. B) Fluorescence micrographs of 
brittle star saponin fraction on Hela-S3 cancer cells with AO/PI staining.(a-d) untreated cancer cells, treatment with 12.5, 25, 50 µg/ml 
brittle star s in fraction. Mag ification= ×200.




Figure 3. A) Evaluation of apoptosis by Annexin V-FITC method. The cells were exposed with increasing concentration of brittle star 
saponin fraction for 24 h by flow cytometry analysis.(a-d) untreated cancer cells, treatment with 12.5, 25 μg/ml brittle star saponin 
fraction, respectively. B) Apoptotic effect of brittle star saponin fraction on cervical cancer cells estimated by flow cytometry. Flow 
cytometry histogram of untreated and treated HeLa cells with 12.5, 25μg/ml brittle star saponin exhibited increase in sub-G1 region 
demonstrating mediation of an apoptotic cell death in cytotoxicity of brittle star saponin.
 
Figure 3: A) Evaluation of apoptosis by Annexin V-FITC method. The cells were exposed  with 
increasing  concentration of brittle st r saponin fraction for 24 h by flow cytometry analysis.(a-d) 
untreated cancer cells, treatment with 12.5, 25 µg/ml brittle star saponin fraction, respectively. 
B) Apoptotic effect of brittle star saponin fraction on cervical cancer cells estimated by flow 
cytometry. Flow cytometry histogram of  untreated and treated HeLa cells with 12.5, 25µg/ml 
brittle star saponin exhibited increase in sub-G1 region demonstrating  mediation of an apoptotic 
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was assessed by flow cytometry analysis of 
propodium iodide according to the exclusion 
of propodium iodide (PI) by viable cells.  As 
exhibited in Figure 3B, the treatment with 
saponin fraction significantly increased the 
sub-G1 peak, which means that the triggering of 
apoptosis is resulting from DNA fragmentation 
and endonuclease activation. Altogether, the 
results of apoptosis assays show that apoptosis 
is considered as a crucial anti proliferative 
mechanism of brittle star saponin fraction 
treatment.
In order to assess the mechanism of brittle 
star saponin fraction recruitment apoptosis, we 
examined the enzymatic activity of caspase-3 
and caspase-9 colorimetrically. As exhibited in 
Figure 4. the activity of caspase-3, as apoptosis 
executioner enzyme, and caspase-9, as marker of 
intrinsic pathway, were significantly enhanced in 
a dose dependent manner with concentrations of 
11.10 and 11.27 µg/mL (p ≤ 0.001) compared 
with the untreated cancer cells. Thus, increased 
activity of caspase-3 and caspase-9 shows the 
involvement of intrinsic pathway in apoptotic 
activity of brittle star saponin in Hela-S3 cervical 
cancer cells in-vitro.
To understand whether the pro apoptotic 
activity of brittle star saponin was attributed to 
the intracellular ROS levels of Hela-S3 cancer 
cells, the measurement of ROS level was 
performed via fluorochrome-based fluoroscopy 
with DCFH-DA. As indicated in Figure 5. the 
pretreatment of cancerous cells with brittle star 
saponin increased the fluorescence intensity 
compared with the control group, which proved 
that ROS production under treatment with brittle 
star saponin fraction was associated with the 
mitochondrial apoptotic pathway induced in 
cervical cancer cells.
To identify the type of induced pro-apoptotic 
activity of brittle star saponin, the cervical cancer 
cells were exposed to different concentrations of 
saponin and then RT-PCR assay was performed. 
Figure 6. 
shows dose dependently reduction of Bcl-2 
mRNA expression (12.5, 25 µg/mL, p ≤ 0.05, 50 
µg/mL, p ≤ 0.001). As, Bcl-2 family are involved 
in mitochondrial apoptotic pathway, therefore, 
the marked down-regulation Bcl-2 revealed 
that brittle star saponin exerted pro-apoptotic 










Figure 4: Effect of saponin fraction isolated from O.erinaceus on activation of caspase -3 and 
caspase -9. As shown, incubation of Hela-S3 cells with increasing concentration of brittle star 
saponin were enhanced significantly 24 h after treatment. P<0.05 were considered significant 
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Figure 4. Effect of saponin fraction isolated from O.erinaceus on activation of caspase -3 and caspase -9. As shown, incubation of 
Hela-S3 cells with increasing concentration of brittle star saponin were enhanced significantly 24 h after treatment. P<0.05 were 
considered significant between experimental groups and control.












Figure 5: Effect of brittle star saponin fraction on intracellular ROS generation  in Hela-S3 
human cancer cells treated with brittle star saponin using fluorescence microscopy. A) untreated 








Figure 5. Effect of brittle star saponin fraction on intracellular ROS generation in Hela-S3 human cancer cells treated with brittle star 











Figure 6: A) The qualitative changes in the expression of Bcl-2 mRNA under treatment with 
brittle star saponin by RT-PCR. B) The densitometry of gel quantitatively evaluated by image J 





























Figure 6. A) The qualitative changes in the expression of Bcl-2 mRNA under treatment with brittle star saponin by RT-PCR. B) The 
densitometry of gel quantitatively evaluated by image J (n = 3). *P<0.05, **P<0.01 and ***P<0.00 were considered significant.
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Related with marine saponins, Cheng and 
colleagues (2006) examined the anticancer effect 
of asterosaponin1, a novel cytostatic compound 
from starfish, on human glioblastoma cells, and 
showed that this natural agent can significantly 
inhibit glioblastoma cell growth and induce 
apoptosis cell death with the up-regulation 
of Bax and down-regulation of Bcl-2. Thus, 
these results were proposed insights into the 
medical application of asterosaponin 1 in cancer 
chemotherapy (22).  
The survey on the antitumor potential of 
saponin extracted from sea cucumber showed that 
saponin separated from Acaudina leucoprocta 
revealed the highest toxicity toward S180 cancer 
cells with the IC50 concentration of 41.04 µg/
mL indicating the anticancer potency of saponin 
extracted from marine organisms (23). There is 
a controversial survey and limited studies in the 
regard to the biological effect of saponin fraction 
from brittle star. Andersson and coworkers 
(1989) studied the biomedical activity of saponin 
fraction from brittle star and demonstrated that 
these compounds showed antibacterial activity 
against gram-positive bacterium and that only 
poly hydroxylated sterols indicated cytotoxicity 
against JURCAT and YAC-1 lymphoma cells in-
vitro(24).
Conclusion
In summary, our observation elucidated 
that brittle star saponin fraction have a marked 
growth inhibitory effect on Hela-S3 cervical 
cancer, while indicating a less cytotoxic effect 
on HNCF-PI52 normal cells. In addition, the 
anticancer proliferative activity of brittle star 
saponin fraction is associated with triggering 
apoptosis cell death, which was proven by 
fluorescence microscopy, Annexin V-FITC 
staining and flow cytometry. Moreover, the 
increment of ROS intracellular level indicated 
counteracting saponin isolated with stress 
oxidative in cervical cancer cells. The activation 
of caspase-3, caspase-9 and down regulation 
of Bcl-2 mRNA demonstrated mitochondrial 
mediated apoptosis in cervical cancer cells, thus 
delineating brittle star saponin fraction as potent 
anticancer agents in the treatment of cervical 
cancer. 
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